Y-Intercept (HK)’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-88,958
Closed -$2.21M – 1594
2026
Q2
$2.21M Buy
+88,958
New +$2.08M 0.04% 642
2026
Q1
– Sell
-40,675
Closed -$457K – 1548
2025
Q4
$457K Buy
40,675
+6,259
+18% +$71.6K 0.01% 1257
2025
Q3
$398K Sell
34,416
-45,657
-57% -$535K 0.01% 1317
2025
Q2
$980K Buy
80,073
+54,373
+212% +$684K 0.02% 946
2025
Q1
$368K Buy
+25,700
New +$401K 0.03% 835
2024
Q3
– Sell
-10,436
Closed -$208K – 1304
2024
Q2
$208K Buy
+10,436
New +$203K 0.01% 1170

Other funds holding AVNS

Y-Intercept (HK)'s AVNS Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 88,958 shares — an estimated $2.21M sold.

Y-Intercept (HK) first reported a position in AVNS in Q2 2024 and held it in 6 quarters. The position peaked at $2.21M in Q2 2026. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

  • Y-Intercept (HK) reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 88,958 Avanos Medical shares in Q3 2026, an estimated $2.21M.
  • Y-Intercept (HK) first reported a position in Avanos Medical in Q2 2024 and held it in 6 quarters.
  • Y-Intercept (HK)'s Avanos Medical position peaked at $2.21M in Q2 2026.
  • 3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.